Home

Station ausblenden Junior non ligand estrogen pathway nf kappa fulvestrant Randstein Blot Betonung

New insights into acquired endocrine resistance of breast cancer
New insights into acquired endocrine resistance of breast cancer

Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE

IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in  Hormone-Dependent Cancers | HTML
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers | HTML

Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for  Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of  Medicinal Chemistry
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling

Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer  Stemness: Elucidating Molecular Mechanisms and Clinical Significance
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance

EREs).
EREs).

Estrogen receptor-α signaling in post-natal mammary development and breast  cancers | SpringerLink
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink

The role of estrogen receptor beta in breast cancer | Biomarker Research |  Full Text
The role of estrogen receptor beta in breast cancer | Biomarker Research | Full Text

Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor  microenvironment - Abstract - Europe PMC
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC

Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE

Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS

Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene

New insights into acquired endocrine resistance of breast cancer
New insights into acquired endocrine resistance of breast cancer

Estrogen receptor signaling as a target for novel breast cancer  therapeutics - ScienceDirect
Estrogen receptor signaling as a target for novel breast cancer therapeutics - ScienceDirect

Signaling pathways and steroid receptors modulating estrogen receptor α  function in breast cancer
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer

Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE

Regulation of estrogen receptor signaling in breast carcinogenesis and  breast cancer therapy. - Abstract - Europe PMC
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC

Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate  Immobilization and Degradation of Estrogen Receptor-α* - Journal of  Biological Chemistry
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α* - Journal of Biological Chemistry

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of  action | British Journal of Cancer
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer

Non-classical genomic estrogen receptor (ER)/specificity protein and  ER/activating protein-1 signaling pathways in: Journal of Molecular  Endocrinology Volume 41 Issue 5 (2008)
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling

Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017  - Reproductive Medicine and Biology - Wiley Online Library
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library

Estrogen signaling: An emanating therapeutic target for breast cancer  treatment - ScienceDirect
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect

Endocrinotherapy resistance of prostate and breast cancer: Importance of  the NF‑κB pathway (Review)
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling.,Cell Chemical Biology - X-MOL
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL